Dexmedetomidine: new insights

Dexmedetomidine is a potent alpha-2-adrenergic agonist, more selective than clonidine, with widespread actions on the mammalian brain that include sedation, anaesthetic-sparing, analgesia and sympatholytic properties. A large body of recent work supports its favourable profile in improving outcome and long-term brain function in the critically ill. The source of these benefits may lie in the neuroprotective properties that are seen in experimental models and in the clinical setting, in which it can attenuate delirium, preserve sleep architecture, preserve ventilatory drive and decrease sympathetic tone and inflammatory response. Dexmedetomidine may also be a valuable adjuvant when regional anaesthesia is used. Future research should aim at establishing the risk/benefit ratio when used at the bedside.

[1]  K. Ho,et al.  Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis , 2010, Intensive Care Medicine.

[2]  P. Gressens,et al.  Characterization of the Postconditioning Effect of Dexmedetomidine in Mouse Organotypic Hippocampal Slice Cultures Exposed to Oxygen and Glucose Deprivation , 2010, Anesthesiology.

[3]  E. Mascha,et al.  The Correlation Between Bispectral Index and Observational Sedation Scale in Volunteers Sedated with Dexmedetomidine and Propofol , 2009, Anesthesia and analgesia.

[4]  Andrew A. Kramer,et al.  Use of intravenous infusion sedation among mechanically ventilated patients in the United States* , 2009, Critical care medicine.

[5]  C. Murphy,et al.  Dexmedetomidine‐Associated Bradycardia Progressing to Pulseless Electrical Activity: Case Report and Review of the Literature , 2009, Pharmacotherapy.

[6]  C. Brummett,et al.  Perineural Dexmedetomidine Added to Ropivacaine Causes a Dose-dependent Increase in the Duration of Thermal Antinociception in Sciatic Nerve Block in Rat , 2009, Anesthesiology.

[7]  J. Lerman,et al.  Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysis , 2009, Paediatric anaesthesia.

[8]  Jack Chen,et al.  Prevalence of Delirium with Dexmedetomidine Compared with Morphine Based Therapy after Cardiac Surgery: A Randomized Controlled Trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study) , 2009, Anesthesiology.

[9]  P. Knapik,et al.  The effect of dexmedetomidine sedation on brachial plexus block in patients with end-stage renal disease , 2009, European journal of anaesthesiology.

[10]  A. Borgeat,et al.  Sedation and regional anesthesia , 2009, Current opinion in anaesthesiology.

[11]  T. Nick,et al.  A Comparison of Dexmedetomidine with Propofol for Magnetic Resonance Imaging Sleep Studies in Children , 2009, Anesthesia and analgesia.

[12]  N. Sut,et al.  Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. , 2009, Journal of clinical anesthesia.

[13]  Katsuya Kobayashi,et al.  The influences of propofol and dexmedetomidine on circadian gene expression in rat brain , 2009, Brain Research Bulletin.

[14]  Sheng-Nan Wu,et al.  Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. , 2009, British journal of anaesthesia.

[15]  P. Pelosi,et al.  Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug. , 2009, Current drug targets.

[16]  R. Gaspari,et al.  Dexmedetomidine use in general anaesthesia. , 2009, Current drug targets.

[17]  G. Fraser,et al.  Altering intensive care sedation paradigms to improve patient outcomes. , 2009, Critical care clinics.

[18]  M. Maze,et al.  Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal Rats , 2009, Anesthesiology.

[19]  J. Alfa,et al.  Dexmedetomidine anaesthesia for patients with obstructive sleep apnoea undergoing bariatric surgery. , 2009, European journal of anaesthesiology.

[20]  Kathryn A. Lee,et al.  Sleep and delirium in ICU patients: a review of mechanisms and manifestations , 2009, Intensive Care Medicine.

[21]  M. Scheinin,et al.  Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep , 2008, Acta anaesthesiologica Scandinavica.

[22]  Russell R. Miller,et al.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. , 2007, JAMA.

[23]  P. Tonner,et al.  The Effects of Dexmedetomidine on Perinatal Excitotoxic Brain Injury are Mediated by the α2A-Adrenoceptor Subtype , 2006, Anesthesia and analgesia.

[24]  J. Gabor,et al.  Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. , 2003, American journal of respiratory and critical care medicine.

[25]  H. Nolte.  Sedation and regional anaesthesia , 1989 .

[26]  J. Mantz,et al.  Poor sleep quality is associated with late noninvasive ventilation failure in patients with acute hypercapnic respiratory failure , 2010 .

[27]  M. Roizen.  Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: A Randomized Trial , 2010 .